Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0050 (-1.96%) ($7.0050 - $7.0050) on Thu. Jun. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.88% (three month average) | RSI | 23 | Latest Price | $7.0050(-1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.5% a day on average for past five trading days. | Weekly Trend | BCRX declines -7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(27%) EWI(26%) EWJ(25%) ARKG(23%) SDY(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.44% in a week (0% probabilities). VIXM(-28%) VXX(-23%) EDOC(-20%) SHY(-19%) VCIT(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.44% (StdDev 2.88%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.3(-161.38%) | Resistance Level | $8.06 | 5 Day Moving Average | $7.37(-4.95%) | 10 Day Moving Average | $7.83(-10.54%) | 20 Day Moving Average | $8.06(-13.09%) | To recent high | -20.9% | To recent low | 0% | Market Cap | $1.236b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |